VOYA INVESTMENT MANAGEMENT LLC

Position in PRME — Prime Medicine, Inc.

CIK 1068837 ATLANTA, GA

Position in PRME

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$74,309

+$13,949 QoQ

Shares Held

20,138

+16.1% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#116

of 186 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. PRME ranks #163 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	505,219	$250,957,432
2	PTGX	Protagonist Therapeutics, Inc	571,618	$70,068,932
3	SRRK	Scholar Rock Holding Corp	890,607	$48,983,385
4	KRYS	Krystal Biotech, Inc.	124,442	$46,251,357
5	TGTX	Tg Therapeutics, Inc.	819,253	$45,009,759
6	PTCT	Ptc Therapeutics, Inc.	539,319	$43,992,249
7	PRAX	Praxis Precision Medicines, Inc.	122,227	$40,920,376
8	REGN	Regeneron Pharmaceuticals, Inc.	65,505	$40,844,986

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$74,309	20,138	+16.1%	Shares	Defined	2026-08-12
2026-03-31	$60,360	17,345	-0.8%	Shares	Defined	2026-05-12
2025-12-31	$60,693	17,491	+36.1%	Shares	Defined	2026-02-12
2025-09-30	$71,183	12,849	-25.4%	Shares	Defined	2025-10-09
2025-06-30	$42,538	17,222	0.0%	Shares	Defined	2025-08-14
2025-03-31	$34,271	17,222	-5.2%	Shares	Defined	2025-06-18
2024-12-31	$53,065	18,173	-5.3%	Shares	Defined	2025-05-02
2024-09-30	$74,242	19,184	0.0%	Shares	Defined	2025-02-07
2024-06-30	$98,605	19,184	+48.6%	Shares	Defined	2025-02-07
2024-03-31	$90,342	12,906	-20.1%	Shares	Defined	2025-02-07
2023-12-31	$143,177	16,160	0.0%	Shares	Defined	2025-02-07
2023-09-30	$154,166	16,160	+2.6%	Shares	Defined	2025-02-07
2023-06-30	$230,634	15,743	—	Shares	Defined	2025-02-07
No filing history on record for this holder in this stock.